Brandes Investment Partners LP increased its stake in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 17.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 162,969 shares of the medical instruments supplier's stock after buying an additional 24,604 shares during the period. Brandes Investment Partners LP owned 4.81% of Utah Medical Products worth $10,018,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Hotchkis & Wiley Capital Management LLC increased its position in Utah Medical Products by 128.3% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier's stock valued at $5,956,000 after purchasing an additional 50,030 shares during the period. Minerva Advisors LLC increased its position in Utah Medical Products by 85.2% during the 4th quarter. Minerva Advisors LLC now owns 78,389 shares of the medical instruments supplier's stock valued at $4,819,000 after purchasing an additional 36,061 shares during the period. Victory Capital Management Inc. increased its position in Utah Medical Products by 439.0% during the 3rd quarter. Victory Capital Management Inc. now owns 14,408 shares of the medical instruments supplier's stock valued at $964,000 after purchasing an additional 11,735 shares during the period. Allspring Global Investments Holdings LLC increased its position in Utah Medical Products by 838.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 11,698 shares of the medical instruments supplier's stock valued at $719,000 after purchasing an additional 10,452 shares during the period. Finally, Geode Capital Management LLC increased its position in Utah Medical Products by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 97,080 shares of the medical instruments supplier's stock valued at $6,497,000 after purchasing an additional 8,516 shares during the period. Hedge funds and other institutional investors own 69.60% of the company's stock.
Utah Medical Products Price Performance
NASDAQ UTMD traded down $0.24 during trading on Thursday, reaching $57.41. 10,298 shares of the company's stock traded hands, compared to its average volume of 21,189. The firm has a market cap of $194.73 million, a price-to-earnings ratio of 14.53 and a beta of 0.06. The company's 50 day simple moving average is $60.40 and its two-hundred day simple moving average is $63.31. Utah Medical Products, Inc. has a 12-month low of $56.83 and a 12-month high of $77.33.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.
Utah Medical Products Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th will be issued a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date is Friday, March 14th. Utah Medical Products's dividend payout ratio is currently 30.89%.
Utah Medical Products Profile
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Articles
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
